The total antioxidant capacity and low-molecular antioxidants concentration in plasma in diabetes type 2 patients in different stage of metabolic compensation and concomitant diabetic nephropathy;Całkowita zdolność antyoksydacyjna oraz stȩżenie antyoksydantów drobnocza̧steczkowych w osoczu u chorych na cukrzycȩ typu 2. W różnym okresie wyrównania metabolicznego oraz z towarzysza̧ca̧ nefropatia̧ cukrzycowa̧

Polski Merkuriusz Lekarski

Volumn 18, Issue 103, 2005, Pages 29-32

  Błaszczak, Robert ^a   Kujawski, Krzysztof ^a   Kȩdziora Kornatowska, Kornelia ^b,d   Kornatowski, Tomasz ^b   Kȩdziora, Jozef ^b   Szadujkis Szadurski, Leszek ^b   Markuszewski, Leszek ^a   Rysz, Jacek ^a   Ertel, Danuta ^a   Olszewski, Robert ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c MILITARY INSTITUTE OF MEDICINE   (Poland)

^d Katedra I Klinika Nefrologii   (Poland)

Author keywords

Diabetes; Diabetic nephropathy; Low molecular antioxidants; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; FREE RADICAL; PHYCOERYTHRIN; TROLOX C;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL RESEARCH; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; FLUOROMETRY; HUMAN; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS;

AGED; ANTIOXIDANTS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 13444292537     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ames R.A.: The effect of antihypertensive drugs on serum lipids and lipoprotein II. Non-diuretic drugs. Drugs, 1986, 32, 335-357.
2. Asayama K., Hayashide H., Dobashi K. i wsp.: Antioxidants in the serum of children with insulindependent diabetes mellitus. Free Rad. Biol. Med., 1993, 15, 597-602.
3. Baynes J.W.: Role of oxidative stress in development of complications in diabetes. Diabetes, 1991, 40, 405-412.
4. Baynes J.W., Thorpe S.R.: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 1999, 48, 1-9.
5. Brownlee M.: Glycation and diabetic complications. Diabetes, 1994, 43, 836-841.
6. Cai L., Kang Y.J.: Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc. Toxicol., 2001, 1, 181-193.
7. Craven P.A., De Rubertis F.R.: Protein kinase C is activited in glomeruli from streptozocin diabetic rats: Possible mediation by glucose. J. Clin. Invest., 1989, 83, 1667-1675.
8. DeLange R.J., Glazer N.: Phycoerythrin fluorescence-based assay for peroxy radicals: a screen for biologically relevant protective agents. Analytical Biochem., 1980, 177, 300-306.
9. Godin D.V. Wohaieb S.A., Gamett M.E. i wsp.: Antioxidant enzyme alterations in experimental and clinical diabetes. Mol. Cell. Biochem., 1988, 84, 223-231.
10. Ha H., Kim K.H.: Role of oxidative stress in the development of the diabetic nephropathy. Kidney Int., 1995, 48, Suppl. 51, 18-21.
11. Hagglof B., Halhnans G., Hohngren G.: Cu, Zn superoxide dismutase, Mn superoxide dismutase and glutathione peroxidase in lymphocytes and erythrocytes in insulindependent diabetes children. Acta Endocrinol., 1983, 102, 235-239.
12. Ido Y., Kilo C., Williamsom J.R.: Interactions between the sorbitol pathway, nonenzymatic glycation, and diabetic vascular dysfunction. Nephrol. Dial. Tranplant., 1996, 11, 240-245.
13. Kedziora-Kornatowska K., Szram S., Kornatowski T. i wsp.: Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement thickness in diabetic kidney. Nephron. Exp. Nephrol., 2003, 95, 134-143.
14. Kedziora-Kornatowska K., Luciak M., Blaszczyk J. i wsp.: Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol. Dial. Transplant., 1998, 13, 2829-32.
15. Kowalska I.: Patogeneza przewlekłych powikłań cukrzycy. Endokrynol. Pol., 2001, 52, 311-321.
16. Ksia̧żek K., Wiśniewska J.: The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus. Przegl. Lek., 2001, 58, 915-918.
17. Majchrzak A., Zozulińska D., Wierusz-Wysocka B.: Znaczenie stresu oksydacyjnego w patogenezie przewlekłych powikłań cukrzycy. Diabet. Pol., 1998, 5, 256-261.
18. Meister A.: Glutathione metabolism and its selective modification. J. Biol. Chem., 1988, 263, 17205-17208.
19. Nagano S., Kurokawa M., Ebara T., i wsp.: Decrease of serum ascorbic acid concentrations in patients with diabetic microangiopathy. J. Nut. Sci. Vitaminol., 1996, 42, 1-9.
20. Opara E.C.: Oxidative stress. Micronutrients, diabetes mellitus and its complications. J.R. Soc. Health, 2002, 122, 28-34.
21. Salahudeen A.K., Kanji V., Reckelhoff J.F. i wsp.: Pathogenesis of diabetic nephropathy:a radical approach. Nephrol. Dial. Transplant., 1997, 12, 664-668.
22. Sinclair A.J., Girling A.J., Gray L.L. i wsp.: Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia, 1991, 34, 171-175.
23. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. NEJM, 1993, 329, 977-982.
24. Tomlinson K.C., Gardiner S.M., Hebden A. i wsp.: Functional consequence of streptozotocin-induced diabetes mellitus with particule reference to the cardiovascular system. Pharmacol. Rev., 1992, 44, 104-131.
25. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonyloureas or insulin compered with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998, 352, 837-853.
26. Vlassara H.: Advanced glycation in diabetic renal and vascular disease. Kidney Int., 1995, 48, Suppl. 51, 43-44.
27. Wierusz-Wysocka B., Wysocki H., Byks H., i wsp.: Metabolic control quality and free radical activity in diabetics patients. Diabet. Res. Clin. Pract., 1995, 27, 193-197.